Abstract
The early onset of obesity has become a serious public health problem and is accompanied by the low age range of various metabolic diseases. Obesity is strongly associated with the development of Insulin resistance (IR). IR is considered the pathological basis of several metabolic diseases and is associated with a high likelihood of future chronic disease in adulthood. But the onset of IR is highly insidious, and the early development of a predictive model of morbidity is essential to the prevention. Exercise can effectively prevent IR, but the optimal intensity and dose of exercise are controversial. Thus, this narrative review shows the mechanisms, screening, and exercise interventions of IR in obese children and adolescents.
Keywords: exercise, insulin resistance, mechanisms, obese children, prediction model
1. Background
The increasing prevalence of obesity among children and adolescents has become a global public health problem. According to a study including 195 countries worldwide, 107 million children and adolescents were obese in 2015, and the prevalence of obesity among children and adolescents in over 70 countries has doubled since 1970 (1). Obesity can cause the body to produce a variety of metabolic diseases (2–4) and is a major cause of insulin resistance (IR) and prediabetes (5). The incidence of IR is 8.9% in children and adolescents with normal weights, 28.6% in overweight children and adolescents, and 44.3% in obese children and adolescents in China (6).
IR is an abnormal state of decreased insulin sensitivity in body tissues, such as liver and muscle tissues, and is often considered the pathophysiological basis of metabolic diseases (7, 8). IR is not only extremely harmful to adults (9–12) but also to children and is usually accompanied by islet beta-cell dysfunction. The rate of pancreatic beta-cell dysfunction is faster in children and leads to related complications (13). In addition, IR during childhood and adolescence is closely associated with the development of cardiovascular diseases in adulthood (14). Therefore, diagnosing and preventing IR in obese children as early as possible is important. Risk prediction model and exercise intervention are effective means of preventing and treating insulin resistance in obese children.
This narrative review addresses the hazards, causes and mechanisms of insulin resistance in obese children, further summarizes the screening and the effects of exercise interventions on insulin resistance. The research presents a promising picture for the prevention and treatment insulin resistance in obese children.
2. Insulin resistance and health for children and adolescents
The adverse effects of IR are primarily due to the hyperinsulinemia (15), further lead to reduced insulin sensitivity, which represents an important risk factor for the development of type 2 diabetes (T2D) (16) and β-cell dysfunction (17). Besides hyperinsulinaemia, IR often associated with hyperlipidaemia, lipid metabolism disorders, oxidative stress and inflammation (18). In fact, IR has been demonstrated to be a reliable marker in the prediction of cardiovascular risk (19). According to the National Health and Nutrition Examination Survey (NHANES), IR is the most important risk factor for coronary heart disease in young people (20). When IR accured, it increases the risk of cardiovascular disease in the body through various mechanisms (21, 22).
IR not only seriously affects the health status of adults, but also has important harmful effects on children and adolescents, even to a more serious extent than adults. Unlike adults, when insulin sensitivity decreases in children and adolescents, pancreatic β-cells will disproportionately over-secrete insulin to maintain metabolic stability of the body (23), which puts the body in a long-term state of hyperinsulinemia (24); and hyperinsulinemia will be accompanied by an increase in appetite, which will further exacerbate obesity (25), forming a vicious circle. Compensated insulin overproduction also exacerbates oxidative stress, leading to rapid decline in β-cell function and ultimately irreversible damage to β-cell function (26, 27). Yaujnik et al. (14) also found that having IR in childhood leads to a significantly higher risk of developing cardiovascular disease in adulthood.
In addition, studies found that IR may be involved in the pathogenesis of atherosclerosis, based on evidence that the more pronounced the IR in adolescents, the higher the circulating biomarkers of endothelial dysfunction, and the lower the reduction in lipocalins, which act as anti-atherosclerotic agents (28). IR plays a key role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) by promoting lipogenesis in hepatocytes, impairing the inhibition of lipolysis and stimulating the secretion of adipokines and other cytokines (10). Clamping studies in adolescents and young adults suggest that NAFLD is associated with IR, possibly because of increased abdominal visceral obesity (16, 29). In conclusion, IR can be harmful to children and adolescents not only in the present, but also increase the risk of disease in adulthood (14).
3. The mechanisms of obesity-induced insulin resistance
3.1. Insulin receptor defects
Insulin is an important hormone involved in the metabolism of sugars, lipids, and proteins in the human body. Its main physiological functions include promoting the absorption of blood glucose by body tissues, promoting the synthesis of glycogen, and inhibiting the breakdown of glycogen and gluconeogenesis (30). Insulin exerts its biological effects mainly through the phosphatidyl alcohol 3 kinase (PI3K) signaling pathway or the mitogen-activated protein kinase/Ras (MAPK/Ras) pathway (31). The PI3K molecule is composed of a 110 kD catalytic subunit and an 85 kD regulatory subunit, which also contains Src homology-2 (SH2) and Src homology-1 (SH1) structural domain. In this signaling pathway, insulin activates insulin receptor substrate (IRS) by binding to insulin receptor proteins on the cell surface, IRS binds to PI3K and activates it through a cascade effect, and activated PI3K binds to downstream protein kinase B (Akt), which mediates the transport of glucose out of the circulatory system through a series of reactions with glucose transporter protein 4 (GLUT4) (32). When IR occurs in the body, the PI3K signaling pathway of insulin is impaired, and the IRS cascade effect is blocked, preventing glucose from being absorbed and utilized by target tissues in a timely manner (33) (Figure 1).
Figure 1.

Schematic representation Nof obesity-induced insulin resistance. Unhealthy lifestyles (high fat diet or sedentary) can lead to obesity in normal weight children and adolescents. And obesity develops in children and adolescents can causes free fatty acids, IL-6, TNF-α, Leptin or adiponectin raised or oxidative stress. Eventually, this leads to insulin resistance. In addition, Obesity can also lead to the development of hyperlipidemia, hyperinsulinemia or meta-inflammation which promoted IR; And IR in turn promotes hyperlipidemia, hyperinsulinemia or meta-inflammation.
3.2. Obesity
Miao et al. (5) found through a Mendelian randomization study that obesity is a strong causative factor for IR and prediabetes development in the body. Obesity leads to the enlargement of adipocytes and expansion of adipose tissues (34), which secrete a variety of adipokines involved in the body's metabolic and inflammatory processes. The endocrine dysregulation of adipose tissues may be an important factor for metabolic disorders in the body. In addition, obesity increases free fatty acid (FFA) content, facilitates mitochondrial fatty acid transport, and decreases β-oxidation capacity, thereby inhibiting fat oxidation (35), impairing glucose tolerance, and promoting the development of IR (36). Obesity can lead to the disorder of glucolipid metabolism, disorders of adiposity, oxygen stress, and inflammation response in the body, leading to the occurrence and development of IR under one or more factors (Table 1).
Table 1.
The mechanism of obesity-induced insulin resistance.
| Related mechanism | Roles in insulin resistance | References |
|---|---|---|
| Defects in insulin receptor substrate | Reverses insulin-induced phosphorylation in tyrosine residues of IRS-1 and so impairs insulin signal transduction | (32, 33, 147) |
| Disorders of glucose and lipid metabolism | Decrease in insulin receptor phosphorylation | (41–43) |
| Adipokines | Reduces the phosphorylation of the ISR1/2 tyrosine or inhibits islet β-cell function | (58, 60, 64) |
| Metabolic inflammation | Activation of IKKβ/NF-κB and JNK pathways, serine phosphorylation of IRS-1 in the site of 307 | (69, 70, 72, 73) |
| Oxidative stress | Induces oxidative stress, impairs insulin signaling | (75–79) |
| Intestinal flora | Induces chronic inflammation and impairs insulin signaling | (82, 87) |
3.2.1. Disorders of glucose and lipid metabolism
Obesity is usually closely related to glucose, lipid, and protein metabolism disorders in the body, such as elevated FFA (37) and branched chain amino acid (BCAA) levels (38, 39). Elevated FFA concentrations in obese individuals cause the enrichment of triglycerides, long-chain acylcarnitines, and diglycerides (DAGs) in cells or liver (40). In human skeletal muscles, elevated FFA levels lead to DAG enrichment and subsequent PKC activation (41), which in turn inhibits the phosphorylation of tyrosine sites on IRS-1/2 and subsequently leads to IR (42).
In addition, elevated FFA concentrations may increase the secretion of cytokines, such as tumour necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6), leads to IR, through the activation of the nuclear factor kappa-B (NF-kB) pathway (43). The body becomes insulin resistant after 6 h of acute elevation of plasma FFA (44), and a decrease in FFA level significantly alleviates IR in the body (45). Elevated FFA level may be an important trigger for the transition from IR to T2DM (46–48). In addition, obesity-induced impaired intracellular lipid oxidation in skeletal muscles may be an important trigger for IR in the body (36).
3.2.2. Adipokines
In recent years, a series of studies has confirmed that adipose tissue is not only an energy storage organ but also an endocrine organ and can secrete various bioactive factors (49). Numerous adipokines have been identified, including acute-phase cytokines such as C-reactive protein, plasminogen activator inhibitor 1, haptoglobin, TNF-α, IL-6, IL-8, IL-10, CC-motif chemokine ligand 2 (CCL2), CCL5, and C-X-C motif ligand 8 (CXCL8). Among these, leptin, adiponectin are closely associated with the occurrence and development of insulin resistance (50, 51). Lipocalin has a good insulin-sensitizing effect and has thus become a major subject of interest in studies about IR or T2DM due to obesity (52). Lipocalin and its receptor levels are significantly lower than normal levels in patients with IR due to obesity (53–55). In obese IR mice with reduced lipocalin levels due to diet or genetic defects, the exogenous injection of lipocalin improved insulin sensitivity (56), mainly because lipocalin acted through the activation of adenosine monophosphate-activated protein kinase (AMPK) phosphorylation (57). In conclusion, lipocalin can enhance insulin sensitivity and insulin function (58).
In addition to lipocalin, leptin is a protein molecule secreted mainly by adipocytes and plays a role in regulating body weight and body metabolism (59). It can regulate islet β-cell function directly (60) and indirectly through neuronal function (61). The leptin levels of children with IR caused by obesity are significantly higher than those in children with normal weights (62). However, in obese IR children, increased levels of endogenous or exogenous leptin no longer act to reduce body weight through inhibition possibly because of the reduced sensitivity of leptin-related action pathways in the hypothalamus or other central neurons, producing leptin resistance (63). Leptin resistance in the brain leads to the accumulation of triglycerides in the liver, blood, and pancreas, ultimately reducing insulin sensitivity and resulting in IR (64).
3.2.3. Metabolic inflammation
Normal body cells or systems show inflammatory response to changes in homeostasis, including external bacterial stimuli and cell apoptosis, and physiological changes, such as excessive lipid accumulation (65). Inflammatory response is the basis of several pathophysiological responses (66). Low-intensity chronic inflammation caused by obesity is often called metabolic inflammation or meta-inflammation (67). The mechanisms of inflammation leading to IR mainly include inflammatory factors acting on the insulin signaling system to interfere with insulin receptors signal transduction. In addition, research also found that there is an inverse correlation between insulin sensitivity and plasma fibrinogen levels (68). Fibrinogen is frequently elevated in obesity, and reflecting the IL 6–mediated acute phase response, which associated with insulin resistance, endothelial dysfunction, and a prothrombotic profile, contributing to cardiometabolic risk.
TNF-α, secreted by adipocytes, is the most important one. It can contribute to IR by inhibiting glucose transporter type-4 (GLUT-4) expression in skeletal myocytes, cardiomyocytes, and adipocytes (69, 70), and its pathway activity leads to IR (71). In addition, elevated TNF-α levels activate stress-activated protein kinase (cJun-N-terminal-kinase, JNK), which inhibits the phosphorylation of IRS-1/2 leading to IR (72). C-reactive protein is another marker of inflammation associated with IR and metabolic diseases and is a widely used clinical biomarker. C-reactive protein could effect insulin sensitivity and glucose homeostasis through binds to leptin and block leptin signaling (73).
3.2.4. Oxidative stress
Oxidative stress refers to the imbalance between the production and scavenging of oxygen free radicals in the body and leads to the excessive accumulation of reactive oxygen species (ROS) and resulting in damage to body tissues (74). Oxidative stress is closely associated with IR and can lead to IR by inhibiting insulin signaling pathway expression (75, 76), and obesity leads to oxidative stress followed by the stimulation of inflammatory factors through the IKKβ/NF-kB and JNK signaling pathways, thereby inducing IR (77, 78). In addition, oxidative stress inhibits PKB phosphorylation and GLUT-4 expression, ultimately leading to IR (79). In conclusion, the relationship between oxidative stress and IR is usually linked to inflammatory response.
3.2.5. Intestinal flora
More than one trillion microorganisms exist in the human body and are mostly found in the gastrointestinal tract; these microorganisms are influenced by pH, oxygen, and nutritional status (80). Obesity decreases the proportion of Akkermancia muciniphila strains, which have a positive effect on insulin sensitivity (81). The intestinal flora regulates energy uptake and blood lipopolysaccharide levels and induces chronic inflammation leading to IR (82). In addition, microorganisms in vivo can cause IR by inducing increase in lipid level (82). In conclusion, the effect of the intestinal flora on T2DM and IR is exerted mainly through the induction of increases in inflammatory factor levels.
4. Screening and prevention
Currently, diagnostic methods for IR in children and adolescents have two main categories: precise measurement and indirect estimation methods. Precise measurement methods, such as hyperinsulinemic–euglycemic clamp technique (83) and intravenous glucose tolerance test (frequently sampled intravenous glucose tolerance test, FSIVGTT) combined with the micro-model mathematical analysis method (84). The hyperinsulinemic–euglycemic clamp technique is the gold standard for IR diagnosis (83) in vivo, and which involves infusion of insulin at a constant rate (determined by body size) while maintaining the glucose at a fixed concentration. But due to its test time and cost, this method is not widely used in clinical practice. The other type is the indirect estimation method, which is mainly related to fasting insulin, fasting glucose, and indices related to oral glucose tolerance test (OGTT). The commonly used diagnostic methods are homeostasis model assessment index of IR (HOMA-IR) (85), whole body insulin sensitivity index (WBISI) (86), and insulin sensitivity index (ISI) (87). One study on adolescents found that WBISI responds to insulin sensitivity changes earlier and better to the degree of IR than HOMA-IR (88).
However, direct and indirect measurement methods are post hoc diagnosis and cannot effectively provide early warning of IR in obese children and adolescents. In addition, IR is untimely diagnosed because the fasting blood sugar of the body remains in the normal range. Therefore, it is necessary to assess the risk of IR before it occurs through prediction model (89).
The current prediction of IR is mainly based on single-indicator studies, and the largest drawback of such studies is low accuracy. The evolution of IR as a disease is a continuous process involving multiple systems. Therefore, a joint modeling of multiple indicators can effectively increase the accuracy and stability of prediction models and their predictive effects. Rivera et al. (90) found the combination of lipids, cytokines, adipokines, and chemokines, showed a sensitivity and specificity of 93.2% for the identification of IR, which was higher than the effect of a model constructed with a single index. Our research team also constructed an IR risk prediction model based on lipids for obese children, which can be effectively used to predict the risk of IR in obese children (91) (Table 2).
Table 2.
Studies that evaluated the performance of indicators in indentifying IR.
| No. | Author | Study design | Sample | Predictors | Statistical analysis | Main results |
|---|---|---|---|---|---|---|
| 1 | Moreira et al.(148) | Transversal | N = 109, 7–11 years old, 31 normal, 23 overweight, and 55 obese children | BMI; WC; C index | ROC curve | AUC 0.90, 95%CI (0.83–0.97); 0.88, 95%CI (0.79–0.96); 0.78, 95%CI (0.66–0.90); 0.69, 95%CI (0.50–0.87) |
| 2 | Carneiro et al. (149) | Transversal | N = 148, 14.1 ± 2.1 years old, BMI: 23.7 ± 4.7 kg/m2 | C index; WC; WHtR | ROC curve and logistic regression | High predictive accuracy for IR: (AUC 0.696, p = 0.008; 0.705, p = 0.004; 0.702, p < 0.001) |
| 3 | Manios et al. (150) | Transversal | N = 248 (109 boys), 10.46 ± 0.36 years old, BMI: 19.95 ± 3.89 kg/m2 | BMI; WC; WHtR | Correlation and multiple linear regression | All high correlation with HOMA-IR (p < 0.001) |
| 4 | Hirschler et al. (151) | Transversal | N = 625 (31 boys), 9.6 ± 2.0 years old | WC; BMI | ROC curve and multiple logistic regression | AUC 0.728, 95%CI (0.74, 0.82); 0.77, 95%CI (0.73, 0.82) |
| 5 | Locateli et al. (152) | Transversal | N = 345 (120 boys), 15.4 ± 1.8 years old, overweight or obese | TyG index; TG/HDL-c; TyG index + TG/HDL-c | Spearman's correlation and ROC curve | TyG index: higher predictive accuracy for IR [AUC 0.743, 95%CI (0.690, 0.796)] |
| 6 | Kang et al. (153) | Transversal | N = 221 (168 boys), 11.1 ± 1.5 years old, overweight, and obese children | TyG index | ROC curve and Pearson's correlation | TyG index was well correlated with HOMA-IR (r = 0.41; p < 0.001) |
| 7 | Singhal et al. (154) | Transversal | N = 294 (134 boys), 14.9 ± 0.9 years old, BMI: 21.3 ± 3.8 kg/m2 | Adiponectin | Multiple linear regression | High correlation with HOMA-IR [r = −1.4, 95%CI (−2.7, −0.1), p = 0.03] |
| 8 | Dikaiakou et al. (155) | Transversal | N = 367 (175 boys), 9.9 ± 2.3 years old, BMI: 27.4 ± 4.1 kg/m2 | TyG index | ROC curve and multiple logistic regression and Pearson's correlation | AUC 0.65 which significantly differs from 0.5 (p < 0.001) |
| 9 | Rodríguez-Gutiérrez et al. (156) | Transversal | N = 1,006 (109 boys), 10.46 ± 0.36 years old, BMI: 19.95 ± 3.89 kg/m2 | WC + acanthosis nigricans + pubertal status | ROC curve and multiple logistic regression | AUC 0.849, p < 0.05 |
| 10 | Barchetta et al. (157) | Transversal | N = 909 (433boys), 10.3 ± 3.2 years old; BMI: 27.4 ± 4.4 kg/m2; | SPISE index | ROC curve and Pearson's correlation | Lower basal SPISE was an independent predictor of IGR development [OR = 3.89 (1.65–9.13), p = 0.002; ROC: 0.82 (0.72–0.92), p < 0.001]. |
| 11 | Tantari et al. (158) | Transversal | N = 232 (105 boys), 13.2 (10.8–15.4) years olds, overweight and obesity | SPISE index | ROC curve | A SPISE cut-off ≤ 6.92 or ≤ 6.13 (based on the method used for insulin resistance detection), showed good sensitivity and specificity |
AUC, area under curve; BMI, body mass index; CI, confidence interval; C index, conicity index; HDL-c, high-density lipoproteins cholesterol; HOMA-IR, homeostasis model assessment index of insulin resistance; IGR, impaired glucose regulation; ROC, receiver operating characteristic curve; SPISE index, single point insulin sensitivity estimator; TyG, triglyceride-glucose index; TC, total cholesterol; TG, Triglyceride; WC, waist circumference; WHtR, waist-to-height ratio.
Besides conventional indicators, with the development of technology some new indicators can also be included. Metabolomics can quantify all the metabolic small molecules of organisms and is considered a discipline that can provide the most accurate information based on phenotype (92). Therefore, integrating metabolomics in the IR prediction modeling of obese children, it will most likely be possible to build more stable and accurate models (93, 94). In addition to indicator factors, the method of model construction can also be updated, like machine learning can be used (95, 96).
Although incorporating more indicators or new methods can improve the accuracy of prediction model, the models constructed need to take into account factors such as the simplicity, portability and practicability (97).
5. Exercise intervention on insulin resistance
Exercise is key component of energy expenditure and energy balance. It modulates the increase in mitochondrial substrate oxidation in the liver and skeletal muscle, while decoupling this process from pyruvate and acetyl-CoA-driven lipid synthesis (98). According to the recommendations of the WHO, children and adolescents should have at least 60 min of moderate-to-vigorous aerobic exercise per day (99).
Exercise, an important tool for the prevention and adjunctive treatment of obesity and chronic diseases (100), has a significant effect alleviating lipid metabolism disorders, IR, and insulin sensitivity in obese children and adolescents (101–103). Exercise mainly improves IR by correcting abnormal lipid metabolism (104), decreasing inflammatory response (105–107), increasing glucose transporter protein expression (108), stimulating glycogen uptake (109), and improving the intestinal flora (110). Although exercise can combat IR, no conclusive evidence of the effects of exercise form and intensity or the dose effect of exercise on IR alleviation has been obtained (Figure 2).
Figure 2.
Exercise to improve insulin resistance. Different exercise [aerobic training, high-intensity interval training (HIIT), resistance training, and mixed training] can effective for fat loss, decreased oxidative stress, IL-6, TNF-α and Leptin, ultimately increases insulin sensitivity, which improves IR.
5.1. Different exercise type
Exercise is usually classified as aerobic training, high-intensity interval training (HIIT), resistance training, and mixed training. It is worth noting that exercise intervention should be tailored to the child's age, pubertal stage, developmental level, comorbidities, and preferences, with gradual progression and appropriate supervision.
Aerobic exercise improves insulin sensitivity mainly by reducing visceral adiposity, decreasing plasma inflammatory factor concentrations (IL-6 and TNF-α) (111), increasing lipocalin levels (112), and increasing GLUT4 expression (113). A meta-analysis of obese children and adolescents found that aerobic exercise significantly improves insulin sensitivity in obese children and adolescents (103). A single session of aerobic exercise is effective in improving insulin sensitivity after exercise but for a short duration (114). By contrast, Lee et al. (101) significantly improved insulin sensitivity in 38 obese or overweight insulin-resistant children and adolescents by subjecting them to long-term aerobic exercise intervention (60 min) three times a week at an intensity of 50%–65% peak oxygen uptake (VO2peak) for 6 months. Abdominal visceral adipose tissue (VAT) is an important determinant of IR across all age groups (115). Increased VAT can cause elevated free fatty acid flux to the liver resulting in IR, aerobic training [treadmill/cycle ergometry at 85% of heart rate maximum (HRmax)] can effectively improved IR by decreasing VAT (116).
HIIT has received considerable interest as a new form of time-saving and efficient exercise. It is more appealing to children and adolescents than prolonged endurance exercise and is more likely to encourage them to participate in exercise (117). HIIT is effective in improving insulin sensitivity and IR in obese children and adolescents (118, 119). However, whether HIIT is more effective than moderate intensity continuous training (MICT) in improving insulin sensitivity is unclear. Corte et al. (118) conducted MICT (30 min, 80% HRmax) and HIIT [1 min 100% maximal oxygen uptake (VO2max) + 3 min 50% VO2max, 3–6 cycles] exercise interventions and found that both significantly reduced HOMA-IR, but no significant difference was found. Some studies reported a more pronounced effect of HIIT (120), which may be due to the fact that HIIT increases insulin receptor phosphorylation levels to a higher degree than aerobic exercise (121). Therefore, given that HIIT appeals to children and adolescents, investigating the mechanism of the effect of HIIT in alleviating IR in obese children and adolescents is of great theoretical importance.
Resistance training is widely regarded as the gold standard approach for enhancing muscular fitness in youth while also providing health and physical fitness benefits (122), and resistance training can also effective in improving insulin sensitivity. Lee et al. (101) found that resistance training alone is effective in increasing the rate of glycogen processing in obese children and adolescents after a 60-minute intervention conducted three times a week for 6 months. Resistance training can be equally effective as aerobic training, such as in preventing type 2 diabetes (123). Grøntved et al. (123) found that muscle strength is similarly effective as cardiorespiratory fitness in preserving healthy insulin sensitivity and β-cell function later in life, after more than 12 years of tracking research. In addition, evidence suggests that resistance training is more enjoyable than aerobic training (e.g., running, cycling) in children and adolescents, particularly those who are overweight or obese (124, 125).
In conclusion, different types exercise can effectively improve insulin resistance, and studies also found combined exercise may be more effective (126). For obese children and adolescents more enjoyable exercise type is important.
5.2. Exercise intensity
Exercise intensity determines the energy substrates during exercise, and the different energy substrates produce different metabolic responses to the body (127). Low to moderate intensity is the optimal intensity for fat oxidation, whereas moderate to high intensity is more significant for carbohydrate consumption (128). Metabolomic studies found that moderate intensity is more beneficial for lipid catabolism than high intensity at the same amount of exercise (129). In resting state, the body's energy supply is dominated by fat oxidation, and phosphorylase activity in skeletal muscles increases with exercise intensity. This effect accelerates glycogen breakdown and results in a gradual increase in the proportion of carbohydrate energy supply (130). Obesity is an important causative factor for IR in the body, and fat elimination is theoretically best facilitated when exercise is performed at maximal fat oxidation (Fatmax) (131), which is the most effective in improving IR while other exercise conditions are controlled. Tan et al. (132) found that a Fatmax exercise intervention performed three times per week 12 weeks, significantly improved insulin sensitivity in subjects. Then whether Fatmax is the optimal intervention intensity for IR needs to be further investigated.
Exercise improves IR by increasing lipid oxidation (104). However, in people with chronic metabolic diseases, such as obesity or T2DM, abnormalities in glycogen to lipid oxidation conversion and decreased lipid oxidation capacity occur, that is, impaired metabolic flexibility (133–135). Resting energy consumption was significantly higher in insulin-resistant than in non-insulin-resistant obese children and adolescents, and the proportion of fat energy supply was significantly lower in insulin-resistant children and adolescents, but the proportion of carbohydrate energy supply was significantly higher (136, 137). Studies on insulin-resistant obese adults found that the maximum rate of fat oxidation during exercise was significantly lower than that of the obese non-insulin-resistant group (137, 138). Moreover, studies on diabetic populations found that the rate of fat oxidation during exercise at 20%, 30%, 40%, 50%, and 60% of maximal aerobic capacity were significantly lower than that of the non-diabetic population (139). This finding suggested significant differences in resting and exercise energy consumption between IR obese children and adolescents and between no-IR obese adolescents and normal-weight children and adolescents.
In conclusion, accurate metabolic characteristics is needed to define exercise intensity criteria of IR obese children and adolescents before develop a personalized exercise prescription.
5.3. Exercise dose response
A “dose-effect” relationship was found between the amount of exercise and improved insulin sensitivity. Davis et al. (140) found that high-dose exercise (40 min/day) for 5 days per week is more effective than low-dose exercise (20 min/day) in improving insulin sensitivity and body fat levels in a study of obese children and adolescents that performed the same exercise intensity. Months after the intervention, low-volume and moderate-intensity and high-volume and-high intensity interventions were more effective in improving insulin sensitivity than the low-volume and high-intensity intervention, and the length of the intervention was more important. Exercise dose is composed of exercise intensity, exercise frequency, and exercise duration. This finding suggests that increase in exercise duration increases energy consumption and alleviates lipid metabolism disorders and IR.
No reports related to the minimum dose of exercise for alleviating IR in obese children and adolescents has been published. Nevertheless, on the basis of some studies on insulin sensitivity or diabetes incidence, we can infer that the effect for exercise for alleviating IR has a threshold. Studies on adults found that a single exercise with an energy consumption of 900 kcal effectively improves insulin sensitivity (141); As for long-term exercises, a minimum of 400 kcal of exercise per week significantly improves insulin sensitivity (142).
In addition, the alleviation of IR in obese children may not have a linear relationship with exercise dose. Studies on adults about the association of physical activity with the risk of developing T2DM confirmed this conjecture. Kyu et al. (143) found that the risk of developing T2DM was reduced by 2% when physical activity reached 600 MEs minutes per week compared relative to that in a sedentary and less active population and by another 19% when physical activity was increased to 3,600 METs minutes per week. However, when physical activity was increased from 9,000 METs minutes to 12,000 METs minutes, the risk was reduced by only 0.6%, suggesting that the dose-effect relationship between physical activity and T2DM may not be completely linear.
In conclusion, exercise can improve IR in obese children and adolescents with IR, but the specific quantitative effect relationship needs to be further investigated in combination with the optimal exercise intensity.
6. Summary and future directions
IR caused by obesity can induce the occurrence of T2DM, cardiovascular diseases, and cancer, but it is often overlooked because of the absence of obvious physiopathological manifestations in the early stage. Early prevention is far more meaningful than post-treatment. Accordingly assess risk of IR in obese adolescents is absolutely essential, predictive modeling can effectively screen out high-risk factors for the development of IR, so that targeted measures can be taken in subsequent prevention.
Exercise intervention can improve IR, and exercise intensity is closely related to the improvement effect, due to obese children and adolescents with IR have abnormal glucose and lipid metabolism such as metabolic flexibility disorders (144, 145), it is necessary to redefine the exercise intensity standard in people with IR in future studies. In addition, there is a nonlinear dose-response relationship between the improvement effect and the exercise dosage (142), and it is important to explore the specific dose-response relationship for the formulation of precise exercise prescription. Besides programmed exercise interventions, levels of daily physical activity are strongly associated with IR. In future studies, attention should be paid to the level of physical activity of obese children and adolescents, so as to achieve the improvement effect of IR by changing life behaviors. However, it is worth noting that to customized an exercise program requires personalization and should be tailored according to the specific circumstances of the children and adolescents like age, pubertal stage, developmental level, comorbidities, and preferences, with gradual progression and appropriate supervision.
For children and adolescents, a daily dose of safe and vigorous physical activity can be effectively integrated into the school day through daily fitness-focused physical education classes, recess periods, and other structured physical activity opportunities. Schools represent a strategic setting for implementing such public health interventions (146). Exercise interventions with fun, simple games that minimize barriers to participation. Using heart rate or rating of perceived exertion (RPE) as a physiological index of exercise intensity and providing contingent rewards for such exertion, encourage even less-fit children to engage in exercise intense enough to improve metabolic health.
Funding Statement
The author(s) declared that financial support was received for this work and/or its publication. This work was supported by “1 + 1” Excellent Academic Team (Project Cultivation) (XSTD202405) and Jiangsu Provincial “Qinglan Project” Outstanding Young Backbone Teacher Training Program (2023).
Footnotes
Edited by: Michelle Plusquin, University of Hasselt, Belgium
Reviewed by: Nick Giesberts, University of Hasselt, Belgium
Rodica Traistaru, University of Medicine and Pharmacy of Craiova, Romania
Author contributions
YC: Writing – original draft, Writing – review & editing. RX: Conceptualization, Funding acquisition, Investigation, Resources, Writing – original draft. JZ: Conceptualization, Investigation, Resources, Writing – original draft.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
- 1.Collaborators GBDO, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. (2017) 377(1):13–27. 10.1056/NEJMoa1614362 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Neeland IJ, Turer AT, Ayers CR, Powell-Wiley TM, Vega GL, Farzaneh-Far R, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA. (2012) 308(11):1150–9. 10.1001/2012.jama.11132 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Neeland IJ, Ayers CR, Rohatgi AK, Turer AT, Berry JD, Das SR, et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity (Silver Spring). (2013) 21(9):E439–47. 10.1002/oby.20135 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Gastaldelli A, Cusi K, Pettiti M, Hardies J, Miyazaki Y, Berria R, et al. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects. Gastroenterology. (2007) 133(2):496–506. 10.1053/j.gastro.2007.04.068 [DOI] [PubMed] [Google Scholar]
- 5.Miao Z, Alvarez M, Ko A, Bhagat Y, Rahmani E, Jew B, et al. The causal effect of obesity on prediabetes and insulin resistance reveals the important role of adipose tissue in insulin resistance. PLoS Genet. (2020) 16(9):e1009018. 10.1371/journal.pgen.1009018 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Yin J, Li M, Xu L, Wang Y, Cheng H, Zhao X, et al. Insulin resistance determined by homeostasis model assessment (HOMA) and associations with metabolic syndrome among Chinese children and teenagers. Diabetol Metab Syndr. (2013) 5(1):71. 10.1186/1758-5996-5-71 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. (1988) 37(12):1595–607. 10.2337/diab.37.12.1595 [DOI] [PubMed] [Google Scholar]
- 8.Lee JM. Insulin resistance in children and adolescents. Rev Endocr Metab Disord. (2006) 7(3):141–7. 10.1007/s11154-006-9019-8 [DOI] [PubMed] [Google Scholar]
- 9.Adeva-Andany MM, Martínez-Rodríguez J, González-Lucán M, Fernández-Fernández C, Castro-Quintela E. Insulin resistance is a cardiovascular risk factor in humans. Diabetes Metab Syndr. (2019) 13(2):1449–55. 10.1016/j.dsx.2019.02.023 [DOI] [PubMed] [Google Scholar]
- 10.Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metab Clin Exp. (2016) 65(8):1038–48. 10.1016/j.metabol.2015.12.012 [DOI] [PubMed] [Google Scholar]
- 11.Seriolo B, Ferrone C, Cutolo M. Longterm anti-tumor necrosis factor-alpha treatment in patients with refractory rheumatoid arthritis: relationship between insulin resistance and disease activity. J Rheumatol. (2008) 35(2):355–7. [PubMed] [Google Scholar]
- 12.Argirion I, Weinstein SJ, Männistö S, Albanes D, Mondul AM. Serum insulin, glucose, indices of insulin resistance, and risk of lung cancer. Cancer Epidemiol Biomarkers Prev. (2017) 26(10):1519–24. 10.1158/1055-9965.EPI-17-0293 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab. (2011) 96(1):159–67. 10.1210/jc.2010-1642 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Yajnik CS, Katre PA, Joshi SM, Kumaran K, Bhat DS, Lubree HG, et al. Higher glucose, insulin and insulin resistance (HOMA-IR) in childhood predict adverse cardiovascular risk in early adulthood: the Pune children’s study. Diabetologia. (2015) 58(7):1626–36. 10.1007/s00125-015-3602-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metab Clin Exp. (2021) 119:154766. 10.1016/j.metabol.2021.154766 [DOI] [PubMed] [Google Scholar]
- 16.Levy-Marchal C, Arslanian S, Cutfield W, Sinaiko A, Druet C, Marcovecchio ML, et al. Insulin resistance in children: consensus, perspective, and future directions. J Clin Endocrinol Metab. (2010) 95(12):5189–98. 10.1210/jc.2010-1047 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Gungor N, Bacha F, Saad R, Janosky J, Arslanian S. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? Diabetes Care. (2005) 28(3):638–44. 10.2337/diacare.28.3.638 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. (2018) 98(4):2133–223. 10.1152/physrev.00063.2017 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol. (2007) 49(21):2112–9. 10.1016/j.jacc.2007.01.088 [DOI] [PubMed] [Google Scholar]
- 20.Eddy D, Schlessinger L, Kahn R, Peskin B, Schiebinger R. Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis. Diabetes Care. (2009) 32(2):361–6. 10.2337/dc08-0854 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zuñiga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. (2018) 17(1):122. 10.1186/s12933-018-0762-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Laakso M, Kuusisto J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat Rev Endocrinol. (2014) 10(5):293–302. 10.1038/nrendo.2014.29 [DOI] [PubMed] [Google Scholar]
- 23.Valaiyapathi B, Gower B, Ashraf AP. Pathophysiology of type 2 diabetes in children and adolescents. Curr Diabetes Rev. (2020) 16(3):220–9. 10.2174/18756417OTA50ODUuTcVY [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Ighbariya A, Weiss R. Insulin resistance, prediabetes, metabolic syndrome: what should every pediatrician know? J Clin Res Pediatr Endocrinol. (2017) 9(Suppl 2):49–57. 10.4274/jcrpe.2017.S005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Temneanu OR, Trandafir LM, Purcarea MR. Type 2 diabetes mellitus in children and adolescents: a relatively new clinical problem within pediatric practice. J Med Life. (2016) 9(3):235–9. [PMC free article] [PubMed] [Google Scholar]
- 26.Del Prato S, Penno G, Miccoli R. Changing the treatment paradigm for type 2 diabetes. Diabetes Care. (2009) 32(Suppl 2):S217–22. 10.2337/dc09-S314 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Defronzo RA. Banting lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. (2009) 58(4):773–95. 10.2337/db09-9028 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Lee S, Gungor N, Bacha F, Arslanian S. Insulin resistance: link to the components of the metabolic syndrome and biomarkers of endothelial dysfunction in youth. Diabetes Care. (2007) 30(8):2091–7. 10.2337/dc07-0203 [DOI] [PubMed] [Google Scholar]
- 29.Deivanayagam S, Mohammed BS, Vitola BE, Naguib GH, Keshen TH, Kirk EP, et al. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents. Am J Clin Nutr. (2008) 88(2):257–62. 10.1093/ajcn/88.2.257 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Mayer JP, Zhang F, DiMarchi RD. Insulin structure and function. Biopolymers. (2007) 88(5):687–713. 10.1002/bip.20734 [DOI] [PubMed] [Google Scholar]
- 31.Xu Y, Fu JF, Chen JH, Zhang ZW, Zou ZQ, Han LY, et al. Sulforaphane ameliorates glucose intolerance in obese mice via the upregulation of the insulin signaling pathway. Food Funct. (2018) 9(9):4695–701. 10.1039/C8FO00763B [DOI] [PubMed] [Google Scholar]
- 32.Tokarz VL, MacDonald PE, Klip A. The cell biology of systemic insulin function. J Cell Biol. (2018) 217(7):2273–89. 10.1083/jcb.201802095 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Schwartz B, Jacobs DR, Jr., Moran A, Steinberger J, Hong CP, Sinaiko AR. Measurement of insulin sensitivity in children: comparison between the euglycemic-hyperinsulinemic clamp and surrogate measures. Diabetes Care. (2008) 31(4):783–8. 10.2337/dc07-1376 [DOI] [PubMed] [Google Scholar]
- 34.DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia. (2010) 53(7):1270–87. 10.1007/s00125-010-1684-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Fritzen AM, Lundsgaard AM, Kiens B. Tuning fatty acid oxidation in skeletal muscle with dietary fat and exercise. Nat Rev Endocrinol. (2020) 16(12):683–96. 10.1038/s41574-020-0405-1 [DOI] [PubMed] [Google Scholar]
- 36.Lundsgaard AM, Fritzen AM, Nicolaisen TS, Carl CS, Sjøberg KA, Raun SH, et al. Glucometabolic consequences of acute and prolonged inhibition of fatty acid oxidation. J Lipid Res. (2020) 61(1):10–9. 10.1194/jlr.RA119000177 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Opie LH, Walfish PG. Plasma free fatty acid concentrations in obesity. N Engl J Med. (1963) 268:757–60. 10.1056/NEJM196304042681404 [DOI] [PubMed] [Google Scholar]
- 38.She P, Reid TM, Bronson SK, Vary TC, Hajnal A, Lynch CJ, et al. Disruption of BCATm in mice leads to increased energy expenditure associated with the activation of a futile protein turnover cycle. Cell Metab. (2007) 6(3):181–94. 10.1016/j.cmet.2007.08.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Lee A, Jang HB, Ra M, Choi Y, Lee HJ, Park JY, et al. Prediction of future risk of insulin resistance and metabolic syndrome based on Korean boy’s metabolite profiling. Obes Res Clin Pract. (2015) 9(4):336–45. 10.1016/j.orcp.2014.10.220 [DOI] [PubMed] [Google Scholar]
- 40.Boden G, Lebed B, Schatz M, Homko C, Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes. (2001) 50(7):1612–7. 10.2337/diabetes.50.7.1612 [DOI] [PubMed] [Google Scholar]
- 41.Itani SI, Ruderman NB, Schmieder F, Boden G. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes. (2002) 51(7):2005–11. 10.2337/diabetes.51.7.2005 [DOI] [PubMed] [Google Scholar]
- 42.Yu C, Chen Y, Cline GW, Zhang D, Zong H, Wang Y, et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem. (2002) 277(52):50230–6. 10.1074/jbc.M200958200 [DOI] [PubMed] [Google Scholar]
- 43.Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes. (2011) 18(2):139–43. 10.1097/MED.0b013e3283444b09 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, Berria R, et al. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes. (2005) 54(6):1640–8. 10.2337/diabetes.54.6.1640 [DOI] [PubMed] [Google Scholar]
- 45.Santomauro AT, Boden G, Silva ME, Rocha DM, Santos RF, Ursich MJ, et al. Overnight lowering of free fatty acids with acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. Diabetes. (1999) 48(9):1836–41. 10.2337/diabetes.48.9.1836 [DOI] [PubMed] [Google Scholar]
- 46.Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev. (2007) 87(2):507–20. 10.1152/physrev.00024.2006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. (2005) 365(9468):1415–28. 10.1016/S0140-6736(05)66378-7 [DOI] [PubMed] [Google Scholar]
- 48.Frayn KN, Williams CM, Arner P. Are increased plasma non-esterified fatty acid concentrations a risk marker for coronary heart disease and other chronic diseases? Clin Sci (Lond). (1996) 90(4):243–53. 10.1042/cs0900243 [DOI] [PubMed] [Google Scholar]
- 49.Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. (2004) 89(6):2548–56. 10.1210/jc.2004-0395 [DOI] [PubMed] [Google Scholar]
- 50.Luo Y, Luo D, Li M, Tang B. Insulin resistance in pediatric obesity: from mechanisms to treatment strategies. Pediatr Diabetes. (2024) 2024:2298306. 10.1155/2024/2298306 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Landecho MF, Tuero C, Valentí V, Bilbao I, de la Higuera M, Frühbeck G. Relevance of leptin and other adipokines in obesity-associated cardiovascular risk. Nutrients. (2019) 11(11):2664. 10.3390/nu11112664 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. (2002) 8(7):731–7. 10.1038/nm724 [DOI] [PubMed] [Google Scholar]
- 53.Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. (2006) 116(7):1784–92. 10.1172/JCI29126 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Yadav A, Kataria MA, Saini V, Yadav A. Role of leptin and adiponectin in insulin resistance. Clin Chim Acta. (2013) 417:80–4. 10.1016/j.cca.2012.12.007 [DOI] [PubMed] [Google Scholar]
- 55.Lihn AS, Pedersen SB, Richelsen B. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev. (2005) 6(1):13–21. 10.1111/j.1467-789X.2005.00159.x [DOI] [PubMed] [Google Scholar]
- 56.Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. (2001) 7(8):941–6. 10.1038/90984 [DOI] [PubMed] [Google Scholar]
- 57.Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. (2002) 8(11):1288–95. 10.1038/nm788 [DOI] [PubMed] [Google Scholar]
- 58.Wang C, Mao X, Wang L, Liu M, Wetzel MD, Guan KL, et al. Adiponectin sensitizes insulin signaling by reducing p70 S6 kinase-mediated serine phosphorylation of IRS-1. J Biol Chem. (2007) 282(11):7991–6. 10.1074/jbc.M700098200 [DOI] [PubMed] [Google Scholar]
- 59.Flier JS. Obesity wars: molecular progress confronts an expanding epidemic. Cell. (2004) 116(2):337–50. 10.1016/S0092-8674(03)01081-X [DOI] [PubMed] [Google Scholar]
- 60.Karpichev IV, Cornivelli L, Small GM. Multiple regulatory roles of a novel Saccharomyces cerevisiae protein, encoded by YOL002c, in lipid and phosphate metabolism. J Biol Chem. (2002) 277(22):19609–17. 10.1074/jbc.M202045200 [DOI] [PubMed] [Google Scholar]
- 61.Kharroubi I, Rasschaert J, Eizirik DL, Cnop M. Expression of adiponectin receptors in pancreatic beta cells. Biochem Biophys Res Commun. (2003) 312(4):1118–22. 10.1016/j.bbrc.2003.11.042 [DOI] [PubMed] [Google Scholar]
- 62.Martos-Moreno G, Mastrangelo A, Barrios V, García A, Chowen JA, Rupérez FJ, et al. Metabolomics allows the discrimination of the pathophysiological relevance of hyperinsulinism in obese prepubertal children. Int J Obes (Lond). (2017) 41(10):1473–80. 10.1038/ijo.2017.137 [DOI] [PubMed] [Google Scholar]
- 63.Münzberg H, Myers MG, Jr. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci. (2005) 8(5):566–70. 10.1038/nn1454 [DOI] [PubMed] [Google Scholar]
- 64.Saito K, Tobe T, Yoda M, Nakano Y, Choi-Miura NH, Tomita M. Regulation of gelatin-binding protein 28 (GBP28) gene expression by C/EBP. Biol Pharm Bull. (1999) 22(11):1158–62. 10.1248/bpb.22.1158 [DOI] [PubMed] [Google Scholar]
- 65.Singer K, Lumeng CN. The initiation of metabolic inflammation in childhood obesity. J Clin Invest. (2017) 127(1):65–73. 10.1172/JCI88882 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Medzhitov R. Origin and physiological roles of inflammation. Nature. (2008) 454(7203):428–35. 10.1038/nature07201 [DOI] [PubMed] [Google Scholar]
- 67.Hotamisligil GS. Inflammation and metabolic disorders. Nature. (2006) 444(7121):860–7. 10.1038/nature05485 [DOI] [PubMed] [Google Scholar]
- 68.Agostinis-Sobrinho CA, Ramírez-Vélez R, García-Hermoso A, Moreira C, Lopes L, Oliveira-Santos J, et al. Low-grade inflammation and muscular fitness on insulin resistance in adolescents: results from LabMed physical activity study. Pediatr Diabetes. (2018) 19(3):429–35. 10.1111/pedi.12607 [DOI] [PubMed] [Google Scholar]
- 69.Olson AL. Regulation of GLUT4 and insulin-dependent glucose flux. ISRN Mol Biol. (2012) 2012:856987. 10.5402/2012/856987 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol. (2008) 9(5):367–77. 10.1038/nrm2391 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Akash MSH, Rehman K, Liaqat A. Tumor necrosis factor-alpha: role in development of insulin resistance and pathogenesis of type 2 diabetes mellitus. J Cell Biochem. (2018) 119(1):105–10. 10.1002/jcb.26174 [DOI] [PubMed] [Google Scholar]
- 72.Solinas G, Becattini B. JNK at the crossroad of obesity, insulin resistance, and cell stress response. Mol Metab. (2017) 6(2):174–84. 10.1016/j.molmet.2016.12.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Yang M, Qiu S, He Y, Li L, Wu T, Ding N, et al. Genetic ablation of C-reactive protein gene confers resistance to obesity and insulin resistance in rats. Diabetologia. (2021) 64(5):1169–83. 10.1007/s00125-021-05384-9 [DOI] [PubMed] [Google Scholar]
- 74.Reddy VP, Zhu X, Perry G, Smith MA. Oxidative stress in diabetes and Alzheimer’s disease. J Alzheimers Dis. (2009) 16(4):763–74. 10.3233/JAD-2009-1013 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. (2004) 114(12):1752–61. 10.1172/JCI21625 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. (2006) 440(7086):944–8. 10.1038/nature04634 [DOI] [PubMed] [Google Scholar]
- 77.Evans JL, Maddux BA, Goldfine ID. The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal. (2005) 7(7–8):1040–52. 10.1089/ars.2005.7.1040 [DOI] [PubMed] [Google Scholar]
- 78.Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. (2006) 116(7):1793–801. 10.1172/JCI29069 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Hurrle S, Hsu WH. The etiology of oxidative stress in insulin resistance. Biomed J. (2017) 40(5):257–62. 10.1016/j.bj.2017.06.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol. (1999) 65(11):4799–807. 10.1128/AEM.65.11.4799-4807.1999 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci U S A. (2013) 110(22):9066–71. 10.1073/pnas.1219451110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Saad MJ, Santos A, Prada PO. Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology (Bethesda). (2016) 31(4):283–93. 10.1152/physiol.00041.2015 [DOI] [PubMed] [Google Scholar]
- 83.DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. (1979) 237(3):E214–23. 10.1152/ajpendo.1979.237.3.E214 [DOI] [PubMed] [Google Scholar]
- 84.Pratt-Phillips SE, Geor RJ, McCutcheon LJ. Comparison among the euglycemic-hyperinsulinemic clamp, insulin-modified frequently sampled intravenous glucose tolerance test, and oral glucose tolerance test for assessment of insulin sensitivity in healthy standardbreds. Am J Vet Res. (2015) 76(1):84–91. 10.2460/ajvr.76.1.84 [DOI] [PubMed] [Google Scholar]
- 85.Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. (1985) 28(7):412–9. 10.1007/BF00280883 [DOI] [PubMed] [Google Scholar]
- 86.Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. (1999) 22(9):1462–70. 10.2337/diacare.22.9.1462 [DOI] [PubMed] [Google Scholar]
- 87.Soonthornpun S, Setasuban W, Thamprasit A, Chayanunnukul W, Rattarasarn C, Geater A. Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab. (2003) 88(3):1019–23. 10.1210/jc.2002-021127 [DOI] [PubMed] [Google Scholar]
- 88.Wang CL, Liang L, Fu JF, Hong F. Comparison of methods to detect insulin resistance in obese children and adolescents. Zhejiang Da Xue Xue Bao Yi Xue Ban. (2005) 34(4):316–9. 10.3785/j.issn.1008-9292.2005.04.007 [DOI] [PubMed] [Google Scholar]
- 89.Schipper HS, de Ferranti S. Cardiovascular risk assessment and management for pediatricians. Pediatrics. (2022) 150(6):e2022057957. 10.1542/peds.2022-057957 [DOI] [PubMed] [Google Scholar]
- 90.Rivera P, Martos-Moreno G, Barrios V, Suárez J, Pavón FJ, Chowen JA, et al. A novel approach to childhood obesity: circulating chemokines and growth factors as biomarkers of insulin resistance. Pediatr Obes. (2019) 14(3):e12473. 10.1111/ijpo.12473 [DOI] [PubMed] [Google Scholar]
- 91.You-Xiang C, Lin Z. Nomogram model for the risk of insulin resistance in obese children and adolescents based on anthropomorphology and lipid derived indicators. BMC Public Health. (2023) 23(1):275. 10.1186/s12889-023-15181-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Nicholson JK, Lindon JC, Holmes E. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica. (1999) 29(11):1181–9. 10.1080/004982599238047 [DOI] [PubMed] [Google Scholar]
- 93.Pujos-Guillot E, Brandolini M, Pétéra M, Grissa D, Joly C, Lyan B, et al. Systems metabolomics for prediction of metabolic syndrome. J Proteome Res. (2017) 16(6):2262–72. 10.1021/acs.jproteome.7b00116 [DOI] [PubMed] [Google Scholar]
- 94.Rupérez FJ, Martos-Moreno GÁ, Chamoso-Sánchez D, Barbas C, Argente J. Insulin resistance in obese children: what can metabolomics and adipokine modelling contribute? Nutrients. (2020) 12(11):3310. 10.3390/nu12113310 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Ma J, An S, Cao M, Zhang L, Lu J. Integrated machine learning and deep learning for predicting diabetic nephropathy model construction, validation, and interpretability. Endocrine. (2024) 85(2):615–25. 10.1007/s12020-024-03735-1 [DOI] [PubMed] [Google Scholar]
- 96.Wang Y, Aivalioti E, Stamatelopoulos K, Zervas G, Mortensen MB, Zeller M, et al. Machine learning in cardiovascular risk assessment: towards a precision medicine approach. Eur J Clin Invest. (2025) 55(Suppl 1):e70017. 10.1111/eci.70017 [DOI] [PubMed] [Google Scholar]
- 97.Moons KG, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart. (2012) 98(9):691–8. 10.1136/heartjnl-2011-301247 [DOI] [PubMed] [Google Scholar]
- 98.Zhao X, An X, Yang C, Sun W, Ji H, Lian F. The crucial role and mechanism of insulin resistance in metabolic disease. Front Endocrinol (Lausanne). (2023) 14:1149239. 10.3389/fendo.2023.1149239 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Chaput JP, Willumsen J, Bull F, Chou R, Ekelund U, Firth J, et al. 2020 WHO guidelines on physical activity and sedentary behaviour for children and adolescents aged 5-17 years: summary of the evidence. Int J Behav Nutr Phys Act. (2020) 17(1):141. 10.1186/s12966-020-01037-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Pedersen BK, Saltin B. Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. (2015) 25(Suppl 3):1–72. 10.1111/sms.12581 [DOI] [PubMed] [Google Scholar]
- 101.Lee S, Libman I, Hughan K, Kuk JL, Jeong JH, Zhang D, et al. Effects of exercise modality on insulin resistance and ectopic fat in adolescents with overweight and obesity: a randomized clinical trial. J Pediatr. (2019) 206:91–8.e1. 10.1016/j.jpeds.2018.10.059 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Lee S, Bacha F, Hannon T, Kuk JL, Boesch C, Arslanian S. Effects of aerobic versus resistance exercise without caloric restriction on abdominal fat, intrahepatic lipid, and insulin sensitivity in obese adolescent boys: a randomized, controlled trial. Diabetes. (2012) 61(11):2787–95. 10.2337/db12-0214 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Marson EC, Delevatti RS, Prado AK, Netto N, Kruel LF. Effects of aerobic, resistance, and combined exercise training on insulin resistance markers in overweight or obese children and adolescents: a systematic review and meta-analysis. Prev Med. (2016) 93:211–8. 10.1016/j.ypmed.2016.10.020 [DOI] [PubMed] [Google Scholar]
- 104.Pedersen BK, Saltin B. Evidence for prescribing exercise as therapy in chronic disease. Scand J Med Sci Sports. (2006) 16(Suppl 1):3–63. 10.1111/j.1600-0838.2006.00520.x [DOI] [PubMed] [Google Scholar]
- 105.Han Y, Liu Y, Zhao Z, Zhen S, Chen J, Ding N, et al. Does physical activity-based intervention improve systemic proinflammatory cytokine levels in overweight or obese children and adolescents? Insights from a meta-analysis of randomized control trials. Obes Facts. (2019) 12(6):653–68. 10.1159/000501970 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Sirico F, Bianco A, D'Alicandro G, Castaldo C, Montagnani S, Spera R, et al. Effects of physical exercise on adiponectin, leptin, and inflammatory markers in childhood obesity: systematic review and meta-analysis. Child Obes. (2018) 14(4):207–17. 10.1089/chi.2017.0269 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.García-Hermoso A, Ceballos-Ceballos RJ, Poblete-Aro CE, Hackney AC, Mota J, Ramírez-Vélez R. Exercise, adipokines and pediatric obesity: a meta-analysis of randomized controlled trials. Int J Obes (Lond). (2017) 41(4):475–82. 10.1038/ijo.2016.230 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Burgomaster KA, Cermak NM, Phillips SM, Benton CR, Bonen A, Gibala MJ. Divergent response of metabolite transport proteins in human skeletal muscle after sprint interval training and detraining. Am J Physiol Regul Integr Comp Physiol. (2007) 292(5):R1970–6. 10.1152/ajpregu.00503.2006 [DOI] [PubMed] [Google Scholar]
- 109.Sylow L, Kleinert M, Richter EA, Jensen TE. Exercise-stimulated glucose uptake - regulation and implications for glycaemic control. Nat Rev Endocrinol. (2017) 13(3):133–48. 10.1038/nrendo.2016.162 [DOI] [PubMed] [Google Scholar]
- 110.Liu Y, Wang Y, Ni Y, Cheung CKY, Lam KSL, Wang Y, et al. Gut microbiome fermentation determines the efficacy of exercise for diabetes prevention. Cell Metab. (2020) 31(1):77–91.e5. 10.1016/j.cmet.2019.11.001 [DOI] [PubMed] [Google Scholar]
- 111.Pedersen BK. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease. Eur J Clin Invest. (2017) 47(8):600–11. 10.1111/eci.12781 [DOI] [PubMed] [Google Scholar]
- 112.Saunders TJ, Palombella A, McGuire KA, Janiszewski PM, Després JP, Ross R. Acute exercise increases adiponectin levels in abdominally obese men. J Nutr Metab. (2012) 2012:148729. 10.1155/2012/148729 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.O'Gorman DJ, Karlsson HK, McQuaid S, Yousif O, Rahman Y, Gasparro D, et al. Exercise training increases insulin-stimulated glucose disposal and GLUT4 (SLC2A4) protein content in patients with type 2 diabetes. Diabetologia. (2006) 49(12):2983–92. 10.1007/s00125-006-0457-3 [DOI] [PubMed] [Google Scholar]
- 114.Cockcroft EJ, Williams CA, Jackman SR, Bassi S, Armstrong N, Barker AR. A single bout of high-intensity interval exercise and work-matched moderate-intensity exercise has minimal effect on glucose tolerance and insulin sensitivity in 7- to 10-year-old boys. J Sports Sci. (2018) 36(2):149–55. 10.1080/02640414.2017.1287934 [DOI] [PubMed] [Google Scholar]
- 115.Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, et al. Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet. (2003) 362(9388):951–7. 10.1016/S0140-6736(03)14364-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.O'Leary VB, Marchetti CM, Krishnan RK, Stetzer BP, Gonzalez F, Kirwan JP. Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat. J Appl Physiol (1985). (2006) 100(5):1584–9. 10.1152/japplphysiol.01336.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Crisp NA, Fournier PA, Licari MK, Braham R, Guelfi KJ. Adding sprints to continuous exercise at the intensity that maximises fat oxidation: implications for acute energy balance and enjoyment. Metab Clin Exp. (2012) 61(9):1280–8. 10.1016/j.metabol.2012.02.009 [DOI] [PubMed] [Google Scholar]
- 118.Corte de Araujo AC, Roschel H, Picanço AR, do Prado DM, Villares SM, de Sá Pinto AL, et al. Similar health benefits of endurance and high-intensity interval training in obese children. PLoS One. (2012) 7(8):e42747. 10.1371/journal.pone.0042747 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Racil G, Ben Ounis O, Hammouda O, Kallel A, Zouhal H, Chamari K, et al. Effects of high vs. moderate exercise intensity during interval training on lipids and adiponectin levels in obese young females. Eur J Appl Physiol. (2013) 113(10):2531–40. 10.1007/s00421-013-2689-5 [DOI] [PubMed] [Google Scholar]
- 120.Jelleyman C, Yates T, O'Donovan G, Gray LJ, King JA, Khunti K, et al. The effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis. Obes Rev. (2015) 16(11):942–61. 10.1111/obr.12317 [DOI] [PubMed] [Google Scholar]
- 121.Tjønna AE, Lee SJ, Rognmo Ø, Stølen TO, Bye A, Haram PM, et al. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation. (2008) 118(4):346–54. 10.1161/CIRCULATIONAHA.108.772822 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Chaabene H, Ramirez-Campillo R, Moran J, Schega L, Prieske O, Sandau I, et al. The era of resistance training as a primary form of physical activity for physical fitness and health in youth has Come. Sports Med. (2025) 55(9):2073–90. 10.1007/s40279-025-02240-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Grøntved A, Ried-Larsen M, Ekelund U, Froberg K, Brage S, Andersen LB. Independent and combined association of muscle strength and cardiorespiratory fitness in youth with insulin resistance and β-cell function in young adulthood: the European youth heart study. Diabetes Care. (2013) 36(9):2575–81. 10.2337/dc12-2252 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Faigenbaum AD, Lloyd RS, Myer GD. Youth resistance training: past practices, new perspectives, and future directions. Pediatr Exerc Sci. (2013) 25(4):591–604. 10.1123/pes.25.4.591 [DOI] [PubMed] [Google Scholar]
- 125.Goldfield GS, Kenny GP, Alberga AS, Prud'homme D, Hadjiyannakis S, Gougeon R, et al. Effects of aerobic training, resistance training, or both on psychological health in adolescents with obesity: the HEARTY randomized controlled trial. J Consult Clin Psychol. (2015) 83(6):1123–35. 10.1037/ccp0000038 [DOI] [PubMed] [Google Scholar]
- 126.García-Hermoso A, López-Gil JF, Izquierdo M, Ramírez-Vélez R, Ezzatvar Y. Exercise and insulin resistance markers in children and adolescents with excess weight: a systematic review and network meta-analysis. JAMA Pediatr. (2023) 177(12):1276–84. 10.1001/jamapediatrics.2023.4038 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127.Fedewa MV, Gist NH, Evans EM, Dishman RK. Exercise and insulin resistance in youth: a meta-analysis. Pediatrics. (2014) 133(1):e163–74. 10.1542/peds.2013-2718 [DOI] [PubMed] [Google Scholar]
- 128.Houmard JA. Intramuscular lipid oxidation and obesity. Am J Physiol Regul Integr Comp Physiol. (2008) 294(4):R1111–6. 10.1152/ajpregu.00396.2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Huffman KM, Koves TR, Hubal MJ, Abouassi H, Beri N, Bateman LA, et al. Metabolite signatures of exercise training in human skeletal muscle relate to mitochondrial remodelling and cardiometabolic fitness. Diabetologia. (2014) 57(11):2282–95. 10.1007/s00125-014-3343-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Romijn JA, Coyle EF, Sidossis LS, Gastaldelli A, Horowitz JF, Endert E, et al. Regulation of endogenous fat and carbohydrate metabolism in relation to exercise intensity and duration. Am J Physiol. (1993) 265(3 Pt 1):E380–91. 10.1152/ajpendo.1993.265.3.E380 [DOI] [PubMed] [Google Scholar]
- 131.Jiang Y, Tan S, Wang Z, Guo Z, Li Q, Wang J. Aerobic exercise training at maximal fat oxidation intensity improves body composition, glycemic control, and physical capacity in older people with type 2 diabetes. J Exerc Sci Fit. (2020) 18(1):7–13. 10.1016/j.jesf.2019.08.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Tan S, Du P, Zhao W, Pang J, Wang J. Exercise training at maximal fat oxidation intensity for older women with type 2 diabetes. Int J Sports Med. (2018) 39(5):374–81. 10.1055/a-0573-1509 [DOI] [PubMed] [Google Scholar]
- 133.Kelley DE, Simoneau JA. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. J Clin Invest. (1994) 94(6):2349–56. 10.1172/JCI117600 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Kelley DE, Mandarino LJ. Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in noninsulin-dependent diabetes mellitus. J Clin Invest. (1990) 86(6):1999–2007. 10.1172/JCI114935 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135.Kelley DE, Mokan M, Simoneau JA, Mandarino LJ. Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest. (1993) 92(1):91–8. 10.1172/JCI116603 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136.Ten S, Bhangoo A, Ramchandani N, Mueller C, Vogiatzi M, New M, et al. Resting energy expenditure in insulin resistance falls with decompensation of insulin secretion in obese children. J Pediatr Endocrinol Metab. (2008) 21(4):359–67. 10.1515/JPEM.2008.21.4.359 [DOI] [PubMed] [Google Scholar]
- 137.Youxiang C, Lin Z, Zekai C, Weijun X. Resting and exercise metabolic characteristics in obese children with insulin resistance. Front Physiol. (2022) 13:1049560. 10.3389/fphys.2022.1049560 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 138.Cancino Ramírez J, Soto Sánchez J, Zbinden Foncea H, Moreno González M, Leyton Dinamarca B, González Rojas L. Cardiorespiratory fitness and fat oxidation during exercise as protective factors for insulin resistance in sedentary women with overweight or obesity. Nutr Hosp. (2018) 35(2):312–7. 10.20960/nh.1279 [DOI] [PubMed] [Google Scholar]
- 139.Ghanassia E, Brun JF, Fedou C, Raynaud E, Mercier J. Substrate oxidation during exercise: type 2 diabetes is associated with a decrease in lipid oxidation and an earlier shift towards carbohydrate utilization. Diabetes Metab. (2006) 32(6):604–10. 10.1016/S1262-3636(07)70315-4 [DOI] [PubMed] [Google Scholar]
- 140.Davis CL, Pollock NK, Waller JL, Allison JD, Dennis BA, Bassali R, et al. Exercise dose and diabetes risk in overweight and obese children: a randomized controlled trial. Jama. (2012) 308(11):1103–12. 10.1001/2012.jama.10762 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141.Magkos F, Tsekouras Y, Kavouras SA, Mittendorfer B, Sidossis LS. Improved insulin sensitivity after a single bout of exercise is curvilinearly related to exercise energy expenditure. Clin Sci (Lond). (2008) 114(1):59–64. 10.1042/CS20070134 [DOI] [PubMed] [Google Scholar]
- 142.Dubé JJ, Allison KF, Rousson V, Goodpaster BH, Amati F. Exercise dose and insulin sensitivity: relevance for diabetes prevention. Med Sci Sports Exerc. (2012) 44(5):793–9. 10.1249/MSS.0b013e31823f679f [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.Kyu HH, Bachman VF, Alexander LT, Mumford JE, Afshin A, Estep K, et al. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the global burden of disease study 2013. Br Med J. (2016) 354:i3857. 10.1136/bmj.i3857 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144.Galgani JE, Moro C, Ravussin E. Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab. (2008) 295(5):E1009–17. 10.1152/ajpendo.90558.2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 145.Goodpaster BH, Sparks LM. Metabolic flexibility in health and disease. Cell Metab. (2017) 25(5):1027–36. 10.1016/j.cmet.2017.04.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146.Pate RR, Davis MG, Robinson TN, Stone EJ, McKenzie TL, Young JC. Promoting physical activity in children and youth: a leadership role for schools: a scientific statement from the American Heart Association council on nutrition, physical activity, and metabolism (physical activity committee) in collaboration with the councils on cardiovascular disease in the young and cardiovascular nursing. Circulation. (2006) 114(11):1214–24. 10.1161/CIRCULATIONAHA.106.177052 [DOI] [PubMed] [Google Scholar]
- 147.Taniguchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. (2006) 7(2):85–96. 10.1038/nrm1837 [DOI] [PubMed] [Google Scholar]
- 148.Moreira SR, Ferreira AP, Lima RM, Arsa G, Campbell CS, Simões HG, et al. Predicting insulin resistance in children: anthropometric and metabolic indicators. J Pediatr (Rio J). (2008) 84(1):47–52. 10.1590/S0021-75572008000100009 [DOI] [PubMed] [Google Scholar]
- 149.Carneiro IB, Sampaio HA, Carioca AA, Pinto FJ, Damasceno NR. Old and new anthropometric indices as insulin resistance predictors in adolescents. Arq Bras Endocrinol Metabol. (2014) 58(8):838–43. 10.1590/0004-2730000003296 [DOI] [PubMed] [Google Scholar]
- 150.Manios Y, Kourlaba G, Kafatos A, Cook TL, Spyridaki A, Fragiadakis GA. Associations of several anthropometric indices with insulin resistance in children: the children study. Acta Paediatr. (2008) 97(4):494–9. 10.1111/j.1651-2227.2008.00729.x [DOI] [PubMed] [Google Scholar]
- 151.Hirschler V, Ruiz A, Romero T, Dalamon R, Molinari C. Comparison of different anthropometric indices for identifying insulin resistance in schoolchildren. Diabetes Technol Ther. (2009) 11(9):615–21. 10.1089/dia.2009.0026 [DOI] [PubMed] [Google Scholar]
- 152.Locateli JC, Lopes WA, Simões CF, de Oliveira GH, Oltramari K, Bim RH, et al. Triglyceride/glucose index is a reliable alternative marker for insulin resistance in south American overweight and obese children and adolescents. J Pediatr Endocrinol Metab. (2019) 32(10):1163–70. 10.1515/jpem-2019-0037 [DOI] [PubMed] [Google Scholar]
- 153.Kang B, Yang Y, Lee EY, Yang HK, Kim HS, Lim SY, et al. Triglycerides/glucose index is a useful surrogate marker of insulin resistance among adolescents. Int J Obes (Lond). (2017) 41(5):789–92. 10.1038/ijo.2017.14 [DOI] [PubMed] [Google Scholar]
- 154.Singhal A, Jamieson N, Fewtrell M, Deanfield J, Lucas A, Sattar N. Adiponectin predicts insulin resistance but not endothelial function in young, healthy adolescents. J Clin Endocrinol Metab. (2005) 90(8):4615–21. 10.1210/jc.2005-0131 [DOI] [PubMed] [Google Scholar]
- 155.Dikaiakou E, Vlachopapadopoulou EA, Paschou SA, Athanasouli F, Panagiotopoulos Ι, Kafetzi M, et al. Τriglycerides-glucose (TyG) index is a sensitive marker of insulin resistance in Greek children and adolescents. Endocrine. (2020) 70(1):58–64. 10.1007/s12020-020-02374-6 [DOI] [PubMed] [Google Scholar]
- 156.Rodríguez-Gutiérrez N, Villareal-Calderón JR, Castillo EC, García-Rivas G. Prediction of insulin resistance based on anthropometric and clinical variables in children with overweight or obesity at a tertiary center in northeast Mexico. Metab Syndr Relat Disord. (2022) 20(3):174–81. 10.1089/met.2021.0094 [DOI] [PubMed] [Google Scholar]
- 157.Barchetta I, Dule S, Bertoccini L, Cimini FA, Sentinelli F, Bailetti D, et al. The single-point insulin sensitivity estimator (SPISE) index is a strong predictor of abnormal glucose metabolism in overweight/obese children: a long-term follow-up study. J Endocrinol Invest. (2022) 45(1):43–51. 10.1007/s40618-021-01612-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 158.Tantari G, Bassi M, Pistorio A, Minuto N, Napoli F, Piccolo G, et al. SPISE INDEX (single point insulin sensitivity estimator): indicator of insulin resistance in children and adolescents with overweight and obesity. Front Endocrinol (Lausanne). (2024) 15:1439901. 10.3389/fendo.2024.1439901 [DOI] [PMC free article] [PubMed] [Google Scholar]

